Association of throat sensation severity with quality of life in patients with chronic cough
- PMID: 40809204
- PMCID: PMC12340281
- DOI: 10.21037/jtd-2024-1994
Association of throat sensation severity with quality of life in patients with chronic cough
Abstract
Background: Patients with chronic cough frequently present with abnormal throat sensations, but the clinical significance of such sensations remains unknown. This study examined the severity of throat sensations and their relationships with quality of life (QoL) in patients with chronic cough.
Methods: The analysis used baseline cross-sectional data from the Korean Chronic Cough Registry. Throat sensation and cough severity were assessed using visual analog scales (VAS, 0-100) and were categorized into tertiles. Demographics and patient-reported outcomes were compared across the throat sensation severity tertiles. Cough-specific QoL was assessed using the Leicester Cough Questionnaire (LCQ). General health-related QoL was assessed using the standardized EuroQoL 5-Dimension (EQ-5D) instrument.
Results: A total of 649 patients with chronic cough (females: 68.1%) with a mean age of 54.7 years were enrolled. Throat sensation severity VAS scores moderately correlated with cough VAS scores (r=0.469, P<0.001). Patients with more severe throat sensations (tertile 3) were younger and had more concomitant symptom and cough-induced complications than those with less severe throat sensations (tertile 1) (P<0.001). Multivariate regression analysis demonstrated that throat sensation severity remained significantly associated with LCQ score and EQ-5D index, after adjusting for confounders, including cough severity (all P<0.05).
Conclusions: Abnormal throat sensation may independently contribute to impaired QoL in patients with chronic cough, and its longitudinal impact warrants investigation.
Keywords: Chronic cough; globus sensation; quality of life (QoL).
Copyright © 2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2024-1994/coif). W.J.S. serves as an unpaid editorial board member of Journal of Thoracic Disease. W.J.S. declares grants from Merck Sharp & Dohme Corp. and AstraZeneca, consulting fees from Merck, Bellus, AstraZeneca, Shionogi, and GSK, and lecture fees from Merck, AstraZeneca, GSK, Sanofi, and Novartis. The other authors have no conflicts of interest to declare.
Figures



Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Clustering Patients With Chronic Cough Using Reported Sensations and Triggers: Results from the Triggers and Sensations Provoking Coughing Questionnaire.Chest. 2025 Jul 18:S0012-3692(25)00835-9. doi: 10.1016/j.chest.2025.05.049. Online ahead of print. Chest. 2025. PMID: 40684908
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial.Diabetes Obes Metab. 2025 Aug;27(8):4268-4279. doi: 10.1111/dom.16463. Epub 2025 May 14. Diabetes Obes Metab. 2025. PMID: 40365662 Free PMC article. Clinical Trial.
-
Immediate versus delayed versus no antibiotics for respiratory infections.Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6. Cochrane Database Syst Rev. 2023. PMID: 37791590 Free PMC article.
References
LinkOut - more resources
Full Text Sources